Gabelli & Co Investment Advisers’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-232,200
Closed -$23.6M 315
2025
Q4
$23.6M Buy
+232,200
New +$18.6M 3.54% 5
2021
Q4
Sell
-2,314
Closed -$221K 498
2021
Q3
$221K Buy
+2,314
New +$244K 0.03% 338
2019
Q3
Sell
-4,356
Closed -$514K 189
2019
Q2
$514K Buy
4,356
+106
+2% +$10.7K 0.06% 115
2019
Q1
$368K Buy
4,250
+100
+2% +$8.51K 0.05% 115
2018
Q4
$262K Buy
+4,150
New +$285K 0.04% 119

Other funds holding EXAS

Gabelli & Co Investment Advisers's EXAS Position: Q1 2026 in Review

Gabelli & Co Investment Advisers sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 232,200 shares — an estimated $23.6M sold.

Gabelli & Co Investment Advisers first reported a position in EXAS in Q4 2018 and held it in 5 quarters. The position peaked at $23.6M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Gabelli & Co Investment Advisers reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 232,200 Exact Sciences shares in Q1 2026, an estimated $23.6M.
  • Gabelli & Co Investment Advisers first reported a position in Exact Sciences in Q4 2018 and held it in 5 quarters.
  • Gabelli & Co Investment Advisers's Exact Sciences position peaked at $23.6M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.